Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
02/01/2007 | DE10301917B4 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Use of substances of the porphyrin synthesis in the phototherapy of skin or joint disease of humans or mammals |
02/01/2007 | CA2616345A1 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
02/01/2007 | CA2615946A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
02/01/2007 | CA2615581A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
01/31/2007 | EP1747204A1 Tri-substituted ureas as cytokine inhibitors |
01/31/2007 | EP1747202A1 Indazole derivatives and pharmaceutical compositions containing them |
01/31/2007 | EP1747192A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands |
01/31/2007 | EP1747008A2 Crude extracts from andrographis paniculata |
01/31/2007 | EP1746986A1 Active substance combination comprising a carbinol combined to at least an nsaid |
01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
01/31/2007 | CN1906203A Glycosaminoglycan (GAG) mimetics |
01/31/2007 | CN1904606A Angelice dehurica crude drug alcoholic extract effective component group fingerprint atlas and its establishing method and application |
01/31/2007 | CN1903358A Compound bone peptide medicine composition oral prepn. and prepn. method therefor |
01/31/2007 | CN1903354A Traditional Chinese medicine for treating lumbago and skelalgia |
01/31/2007 | CN1903353A Gushang Zhongtongling ointment for treating bone injury |
01/31/2007 | CN1903336A Traditional Chinese medicine for treating rheumatosis |
01/31/2007 | CN1903330A Traditional Chinese medicine prepn. for treating rheumatismal arthritis and rheumatoid arthritis |
01/31/2007 | CN1903328A Health-care medicated wine for treating fracture and injury, cervical vertebrae ache and lumbar vertebrae ache |
01/31/2007 | CN1903307A Granule or powder preparation for anti-cold and febrifugal electuary, and its extraction method |
01/31/2007 | CN1903299A Traditional Chinese medicine decoction for treating-ache and expelling atagnate |
01/31/2007 | CN1903295A Traditional Chinese medicine plaster for treating arthralgia and lumbago, and its prepn. method |
01/31/2007 | CN1903293A External use medicine for treating rheumatosis and rheumatoid disease, and its prepn. method |
01/31/2007 | CN1903286A Recovery medicated liquor contg. potato and its prepn. method |
01/31/2007 | CN1903284A Micro-pills of Niuhuang Shangqing Wan Contg. calculus Bovis, and its prepn. method |
01/31/2007 | CN1903272A Traditional Chinese medicine prepn. for treating appendicitis |
01/31/2007 | CN1903261A Method for processing monkshood |
01/31/2007 | CN1903259A Method for extraction and separation of moutan bark |
01/31/2007 | CN1903254A Compound medicine for treating wind-heat type cold and preparing method thereof |
01/31/2007 | CN1903241A Method for extraction and separation of pseudo-ginseng |
01/31/2007 | CN1903239A Method for extraction and separation of rhizome of chuanixong |
01/31/2007 | CN1903212A Application of methyl astragalin for preparing medicines |
01/31/2007 | CN1903181A Enteric quick-dissolving tablets contg. aconitine, and its prepn. method |
01/31/2007 | CN1297568C Echinacea polysaccharide, and its preparing method and use for preparing medicines for treating antivirus and antibacterial, especially anti SARS |
01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
01/31/2007 | CN1297309C External medicine composition for curing arthralgia-syndrome of joint and preparation process thereof |
01/31/2007 | CN1297299C Application of cocoa extract in preparing medication of anti irritability and anti inflammation, foodstuff and cosmetic |
01/31/2007 | CN1297289C Chinese medicinal composition for warming and transforming stasis, dispelling dampness and dispersing swell |
01/31/2007 | CN1297285C Becterin of Serratia marcescens for curing |
01/31/2007 | CN1297271C Fat emulsion injection of bulleyaconitine A and its manufacturing method |
01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
01/31/2007 | CN1297264C Loselofen sodium injection and its preparation |
01/31/2007 | CN1297261C Fatty acyl acetaldehyde transfusion preparation and its preparing method |
01/31/2007 | CN1297251C Hot pepper gel for treating rheumatism |
01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
01/30/2007 | US7169905 Modified peptides as therapeutic agents |
01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
01/30/2007 | US7169814 Guanidinium transport reagents and conjugates |
01/30/2007 | US7169809 Reducing risk of thrombotic cardiovascular events such as stroke, myocardial ischemia, myocardial infarction, angina pectoris, and transient ischemic attack; side effect reduction |
01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
01/30/2007 | US7169794 Oxidation of a chemical intermediate |
01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
01/30/2007 | US7169779 Inhibitors of p38 |
01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
01/30/2007 | US7168597 Aerosol metering valve |
01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
01/30/2007 | CA2163363C Stable suppository formulations effecting biovailability of .delta.9-thc |
01/30/2007 | CA2126917C New n-phenyl 2-cyano 3-hydroxy propenamides; tautomers and salts thereof; process for preparing them and their use as therapeutic agents; compositions containing these new product |
01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
01/25/2007 | WO2007011293A1 Novel piperidine derivatives |
01/25/2007 | WO2007010973A1 Utilization of anti-neuropathic pain effect of d-allose and d-psicose |
01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
01/25/2007 | WO2007010692A1 Pharmaceutical composition for treatment of inflammatory bowel disease which targets at hvem and btla, and therapeutic method |
01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
01/25/2007 | WO2007009959A1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
01/25/2007 | WO2007009778A1 Piperidine carboxamide derivate suitable as tachykinin receptor antagonist |
01/25/2007 | WO2007009772A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
01/25/2007 | WO2007009757A1 Purine derivatives as agonists of the adenosine a2a receptor |
01/25/2007 | WO2007009485A1 Substituted 8-phenoxy-y-carboline derivatives with 5ht1 activity |
01/25/2007 | WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
01/25/2007 | WO2006119168A3 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
01/25/2007 | WO2006110654A8 Spiroheterocyclic compounds and their uses as therapeutic agents |
01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
01/25/2007 | US20070021465 antiinflamatory agents such as 3-pyridin-3-yl-5-pyridin-4-yl-4,5-dihydro-1,2-oxazole, that inhibit production and release of certain proinflammatory cytokines such as tumor necrosis factor and high mobility group-1 (HMGB1), a protein that accumulates in serum and mediates delayed lethality |
01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
01/25/2007 | US20070021447 2-Imino-4-(thio)oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
01/25/2007 | US20070021437 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
01/25/2007 | US20070021393 New use of GabaB receptor agonists |